Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Overview of attention for article published in Arthritis Research & Therapy, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 2 news outlets
policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 118 Dimensions

Readers on

mendeley: 151 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Artrite psoriasica, da FUTURE 3 conferme per secukinumab autosomministrato

Pharmastar Italy, 21 Mar 2018

Secukinumab determina un miglioramento sostenuto dei segni e dei sintomi dell'artrite psoriasica (PsA) in pazienti con malattia…

Autoinjected Secukinumab a Hit in Psoriatic Arthritis

MedPage Today, 16 Mar 2018

Action Points Note that this randomized study found that the Il-17a inhibitor secukinumab was efficacious in improving symptoms…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.